Sensyne Health PLC (AIM:SENS, FRA:DSH) (LON: SENS) has signed a strategic research agreement with a US healthcare group giving it access to “de-identified” data from its 3.6mln patients.
The latest tie-up is with Sentara Healthcare, which covers Virginia and north-eastern North Carolina through 12 acute hospitals with more than 300 other sites.
Sensyne is building an extensive medical database that it can interrogate using artificial intelligence. The output will be used in medical research and drug development. It now has access to the records of 2.17mln people.
Jordan Asher, chief physician executive of Sentara, said: "The combination of data and clinical expertise has the power to drive innovation, further advance research and enhance our ability to deliver complex and high-specialized clinical care to the communities we serve.
“The Sensyne partnership has the potential to help our organisation continue our mission of improving health every day in critical areas of healthcare, including health equity."